The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension
<i>Pulmonary</i> arterial hypertension (PAH) is a progressive disorder caused by the narrowing of small blood vessels in the lungs, which, in the absence of therapies, leads to right heart failure and premature death. No cure for this devastating disorder is known. Current management the...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | BioChem |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-6411/4/3/12 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|